Publicacións en colaboración con investigadores/as de University of Pisa (39)

2023

  1. 2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry

    International Journal of Cardiology, Vol. 390

  2. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

    Breast cancer research : BCR, Vol. 25, Núm. 1, pp. 93

  3. Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies

    Rheumatology (United Kingdom), Vol. 62, Núm. 1, pp. 243-255

  4. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

    Annals of the Rheumatic Diseases

  5. Predictive value of tumor budding in head and neck squamous cell carcinoma: an update

    Virchows Archiv, Vol. 483, Núm. 4, pp. 441-449

  6. Psychological Distress in a Sample of Adult Italian Patients Affected by Vocal Nodules and Muscle-Tension Dysphonia: Preliminary Results

    Journal of Voice, Vol. 37, Núm. 2, pp. 300.e21-300.e29

2022

  1. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study

    British Journal of Sports Medicine, Vol. 56, Núm. 20, pp. 1157-1170

  2. coMpliAnce with evideNce-based cliniCal guidelines in the managemenT of acute biliaRy pancreAtitis): The MANCTRA-1 international audit

    Pancreatology, Vol. 22, Núm. 7, pp. 902-916

2021

  1. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

    Nature Communications, Vol. 12, Núm. 1

  2. A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study

    Journal of Medical Virology, Vol. 93, Núm. 2, pp. 983-994

  3. A worldwide survey on proctological practice during COVID-19 lockdown (ProctoLock 2020): a cross-sectional analysis

    Colorectal Disease, Vol. 23, Núm. 1, pp. 246-264

  4. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

    Breast cancer research : BCR, Vol. 23, Núm. 1, pp. 86

  5. Breast cancer risk factors and survival by tumor subtype: Pooled analyses from the breast cancer association consortium

    Cancer Epidemiology Biomarkers and Prevention, Vol. 30, Núm. 4, pp. 623-642

  6. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

    British Journal of Cancer, Vol. 124, Núm. 4, pp. 842-854

  7. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk

    Journal of the National Cancer Institute, Vol. 113, Núm. 3, pp. 329-337

  8. Comorbidities (excluding lymphoma) in Sjögren's syndrome

    Rheumatology (United Kingdom), Vol. 60, Núm. 5, pp. 2075-2084

  9. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078))

    Nature communications

  10. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

    American Journal of Human Genetics, Vol. 108, Núm. 7, pp. 1190-1203

  11. Genetically predicted levels of DNA methylation biomarkers and breast cancer risk: Data from 228 951 women of european descent

    Journal of the National Cancer Institute, Vol. 112, Núm. 3, pp. 295-304

  12. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

    British Journal of Cancer, Vol. 125, Núm. 8, pp. 1135-1145